| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Covalon Technologies Ltd (OTCQX: CVALF)
CVALF Technical Analysis
5
| As on 18th Dec 2024 CVALF STOCK Price closed @ 2.46 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.98 & Strong Buy for SHORT-TERM with Stoploss of 1.25 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CVALFSTOCK Price
| Open | 2.38 | Change | Price | % |
| High | 2.48 | 1 Day | 0.11 | 4.68 |
| Low | 2.38 | 1 Week | -0.26 | -9.56 |
| Close | 2.46 | 1 Month | 0.02 | 0.82 |
| Volume | 7900 | 1 Year | 1.17 | 90.70 |
| 52 Week High 2.88 | 52 Week Low 0.73 | ||||
OTCQX USA Most Active Stocks
| KRRGF | 4.83 | 2.33% |
| FCUUF | 0.52 | -20.00% |
| FNGR | 1.07 | -46.50% |
| GBTC | 76.47 | 0.20% |
| ETHE | 32.63 | 1.21% |
| ZNOG | 0.07 | 0.00% |
| CURLF | 2.04 | 22.89% |
| VRNOF | 1.90 | 24.18% |
| AOTVF | 0.14 | -6.67% |
| CRLBF | 1.26 | 21.15% |
OTCQX USA Top Gainers Stocks
OTCQX USA Top Losers Stocks
| CVALF Daily Charts |
CVALF Intraday Charts |
Whats New @ Bazaartrend |
CVALF Free Analysis |
|
|
CVALF Important Levels Intraday
| RESISTANCE | 2.65 |
| RESISTANCE | 2.59 |
| RESISTANCE | 2.55 |
| RESISTANCE | 2.51 |
| SUPPORT | 2.41 |
| SUPPORT | 2.37 |
| SUPPORT | 2.33 |
| SUPPORT | 2.27 |
CVALF Forecast December 2024
| 4th UP Forecast | 2.92 |
| 3rd UP Forecast | 2.77 |
| 2nd UP Forecast | 2.68 |
| 1st UP Forecast | 2.59 |
| 1st DOWN Forecast | 2.33 |
| 2nd DOWN Forecast | 2.24 |
| 3rd DOWN Forecast | 2.15 |
| 4th DOWN Forecast | 2 |
CVALF Weekly Forecast
| 4th UP Forecast | 2.50 |
| 3rd UP Forecast | 2.49 |
| 2nd UP Forecast | 2.48 |
| 1st UP Forecast | 2.47 |
| 1st DOWN Forecast | 2.45 |
| 2nd DOWN Forecast | 2.44 |
| 3rd DOWN Forecast | 2.43 |
| 4th DOWN Forecast | 2.42 |
CVALF Forecast2024
| 4th UP Forecast | 6.99 |
| 3rd UP Forecast | 5.54 |
| 2nd UP Forecast | 4.64 |
| 1st UP Forecast | 3.74 |
| 1st DOWN Forecast | 1.18 |
| 2nd DOWN Forecast | 0.28 |
| 3rd DOWN Forecast | -0.62 |
| 4th DOWN Forecast | -2.07 |
Covalon Technologies Ltd ( OTCQX USA Symbol : CVALF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CVALF Business Profile
Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, the United Kingdom, Europe, the Middle East, Asia, Latin America, and internationally. The company has five proprietary platform technologies, including collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; antimicrobial silicone adhesive platform that is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity; medical coating platform, a proprietary process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device; aquaguard moisture barrier technology, an impermeable moisture barrier that allows the clinician or patient to cover wounds, dressings, and intravenous sites to keep them dry; and covaguard antimicrobial sanitizing technology that incorporates Benzalkonium Chloride into a lipid delivery system to surfaces and skin to kill viruses and bacteria. Its products include wound care dressings; surgical and peri-operative products; infection management products; moisture barriers; and antimicrobial sanitizers under the Covalon brand name. The company sells its products through third-party distribution networks and company's direct sales force. It serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. The company is headquartered in Mississauga, Canada. Address: 1660 Tech Avenue, Mississauga, ON, Canada, L4W 5S7
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service